3 Results for "

ABBV-CLS-484

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "ABBV-CLS-484" in MCE Product Catalog:

7
7 Cited Publications
Cat. No.: HY-145923
CAS No.: 2489404-97-7
Purity:  99.38%
Synonyms: ABBV-CLS-484
Target:  

Phosphatase STAT JAK

Research Areas:  

Cancer

Osunprotafib (ABBV-CLS-484) is an orally active and selective active site PTPN1 (IC50: 2.5 nM) and PTPN2(IC50: 1.8 nM) inhibitor. Osunprotafib has 6-8-fold weaker activity on PTPN9 and no detectable activity on SHP-1 or SHP-2. Osunprotafib increases the sensitivity of human cancer cell lines to IFNγ. Osunprotafib generates robust anti-tumor immunity by enhancing JAK-STAT signalling and reducing T cell dysfunction .
loading...
    loading...
Cat. No.: HY-162428
CAS No.: 3032920-59-2
Target:  

Phosphatase

Research Areas:  

Cancer

PTPN2/1-IN-3 (compound 4) is a modified, orally active PTPN2/N1 inhibitor based on ABBV-CLS-484 (HY-145923). PTPN2/1-IN-3 has anti-tumor effects, inhibiting PTPN2 with an IC50 of 9.3 nM and having an oral bioavailability of 93% in mice .
loading...
    loading...
Cat. No.: HY-145923B
CAS No.: 2986745-48-4
Synonyms: ABBV-CLS-484 hydrochloride
Target:  

Phosphatase

Research Areas:  

Inflammation/Immunology Cancer

Osunprotafib (ABBV-CLS-484) hydrochloride is an orally active and selective active site PTPN1 (IC50: 2.5 nM) and PTPN2(IC50: 1.8 nM) inhibitor. Osunprotafib hydrochloride has 6-8-fold weaker activity on PTPN9 and no detectable activity on SHP-1 or SHP-2. Osunprotafib hydrochloride increases the sensitivity of human cancer cell lines to IFNγ. Osunprotafib hydrochloride generates robust anti-tumor immunity by enhancing JAK-STAT signalling and reducing T cell dysfunction .
loading...
    loading...